VALBIOTIS (EPA:ALVAL) | Finanzwire

Basculer en Français

10596	Companies
224721	Keywords
153450	Articles
118878	Press releases

Home
Companies
VALBIOTIS

PRESS RELEASE

published on 03/03/2025 at 17:40, 1 year 3 months ago

VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms its strategic and financial goals
Valbiotis unveils its annual financial statements & confirms strategic and financial goals for 2027 & 2030. Company reports fiscal year 2024 results indicating progress and transformation

Financial Statements Valbiotis Annual Results Strategic Goals Commercialization Phase
BRIEF

published on 02/24/2025 at 10:18, 1 year 3 months ago

VALBIOTIS: Monthly Report of Voting Rights and Shares

Share Capital Voting Rights Actions Euronext Growth Valbiotis
BRIEF

published on 02/24/2025 at 10:17, 1 year 3 months ago

VALBIOTIS SA: Monthly update on voting rights and shares

Voting Rights Euronext Actions Valbiotis Financial Regulation
BRIEF

published on 02/17/2025 at 12:05, 1 year 4 months ago

VALBIOTIS: Information on Shares and Voting Rights

Share Capital Voting Rights Euronext Growth Valbiotis Threshold Crossing
BRIEF

published on 02/17/2025 at 12:05, 1 year 4 months ago

Update of the shareholder structure of Valbiotis SA

Share Capital Voting Rights Actions Euronext Growth Valbiotis
BRIEF

published on 01/30/2025 at 17:45, 1 year 4 months ago

Valbiotis to Launch Valbiotis®PRO Metabolic Health in February

Valbiotis Metabolic Health Dietary Supplement TOTUM•63 France Launch
PRESS RELEASE

published on 01/30/2025 at 17:40, 1 year 4 months ago

VALBIOTIS SA: Valbiotis to launch its solution for the prevention of metabolic diseases, Valbiotis®PRO Metabolic Health (Totum•63), on February 3rd
Valbiotis announces the market launch of Valbiotis®PRO Metabolic Health (Totum•63) in France on February 3rd, providing a natural, plant-based solution for metabolic diseases

Valbiotis Metabolic Diseases Metabolic Health Dietary Supplement TOTUM•63
BRIEF

published on 01/21/2025 at 17:45, 1 year 4 months ago

Valbiotis Outlines 2030 Strategic and Financial Targets

Financial Targets Valbiotis International Sales 2030 Goals Cardiometabolic
PRESS RELEASE

published on 01/21/2025 at 17:40, 1 year 4 months ago

VALBIOTIS SA: Valbiotis unveils its strategic and financial goals for 2030
Valbiotis unveils its strategic and financial goals for 2030, focusing on product releases, turnover targets, and international sales expansion. Detailed roadmap and value proposition presented

Valbiotis Strategic Goals International Sales Financial Goals Product Releases
BRIEF

published on 01/14/2025 at 17:49, 1 year 5 months ago

Valbiotis Announces Success in HEART II Study on Lipidrive

Valbiotis Lipidrive Hypercholesterolemia HEART II Study LDL Cholesterol

Accesswire

Published on 06/18/2026 at 15:50, 20 minutes ago

Pentagon I Capital Corp. and Prospectiva Resources Ltd. Announce Financing
Published on 06/18/2026 at 15:00, 1 hour 10 minutes ago

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
Published on 06/18/2026 at 14:30, 1 hour 40 minutes ago

Voting Results from Solitario Resources Corp Annual Meeting Held June 17, 2026
Published on 06/18/2026 at 14:30, 1 hour 40 minutes ago

Rochon Family Executes Strategic Purchase of AIAI Holdings Shares
Published on 06/18/2026 at 14:25, 1 hour 45 minutes ago

Sparton Acquires Option to Past Producing Silver Property and Strengthens Board at AGM

View all ACCESSWIRE

EQS Group

Published on 06/18/2026 at 16:05, 4 minutes ago

Rockwell Automation Introduces FactoryTalk ResilientEdge to Enable Autonomous, Scalable Manufacturing Operations
Published on 06/18/2026 at 16:05, 4 minutes ago

Cision Launches AI Coverage Analysis in CisionOne to Help PR Teams Move from Coverage to Action
Published on 06/18/2026 at 15:27, 43 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/18/2026 at 15:26, 43 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 06/18/2026 at 15:25, 45 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Senior plc

Les Echos

Published on 06/18/2026 at 13:00, 3 hours 10 minutes ago

Edenred statement
Published on 06/18/2026 at 09:06, 7 hours 4 minutes ago

Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany
Published on 06/18/2026 at 08:30, 7 hours 40 minutes ago

OPmobility wins first awards with Chinese automaker Leapmotor outside of China
Published on 06/18/2026 at 07:00, 9 hours 10 minutes ago

bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry
Published on 06/17/2026 at 17:40, 22 hours 30 minutes ago

Report on share repurchases from 10 to 16 June 2026

View all LES ECHOS COMFI WIRE